Relationships between duration of asthma and asthma severity among children in the Childhood Asthma Management Program (CAMP)

Journal of Allergy and Clinical Immunology

Volumn 103, Issue 3, 1999, Pages 376-386

  Zeiger, Robert S ^a,b   Dawson, Christopher ^c   Weiss, Scott ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Asthma duration; Asthma severity; Asthma symptoms and medications; Atopy; Eosinophils; IgE; Lung function; Sex; Skin prick tests

Indexed keywords

ANTIASTHMATIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CROMOGLYCATE DISODIUM; IMMUNOGLOBULIN E; METHACHOLINE; SALBUTAMOL; STEROID;

ARTICLE; ASTHMA; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; EOSINOPHIL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SKIN TEST; SPIROMETRY;

ADRENERGIC BETA-AGONISTS; ALBUTEROL; ALLERGENS; ANTI-ASTHMATIC AGENTS; ANTIGENS, DERMATOPHAGOIDES; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; BRONCHODILATOR AGENTS; CANADA; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; GLYCOPROTEINS; HOUSING; HUMANS; HYPERSENSITIVITY, IMMEDIATE; LINEAR MODELS; MALE; METHACHOLINE CHLORIDE; MULTIVARIATE ANALYSIS; RECEPTORS, ADRENERGIC, BETA-2; SEVERITY OF ILLNESS INDEX; SKIN TESTS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; VITAL CAPACITY;

EID: 0033054157     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0091-6749(99)70460-4     Document Type: Article

References (49)

1. Wahlgren DR, Hovell MF, Matt GE, Meltzer SB, Zakarian JM, Meltzer EO. Toward a simplified measure of asthma severity for applied research. J Asthma 1997;34:291-303.
2. Synek M, Beasley R, Frew AJ, Goulding D, Holloway L, Lampe FC, et al. Cellular infiltration of the airways in asthma of varying severity. Am J Respir Crit Care Med 1996;154:224-30.
3. Sont JK, Han J, van Krieken JM, Evertse CE, Hooijer R, Willems LOG, et al. Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids. Thorax 1996;51:496-502.
4. Djukanovic R, Howarth P, Vrugt B, Wilson S, Semper A, Bradding P, et al. Determinants of asthma severity. Int Arch Allergy Immunol 1995;107:389.
5. Bousquet J, Chanez P, Lacoste JY, Enander I, Venge P, Peterson C, et al. Indirect evidence of bronchial inflammation assessed by titration of inflammatory mediators in BAL fluid of patients with asthma. J Allergy Clin Immunol 1991;88:649-60.
6. Bradley BL, Azzawi M, Jacobson M, Assoufi B, Collins JV, Irani AMA, et al. Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma. Comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. J Allergy Clin Immunol 1991;88:661-74.
7. Jeffrey PK, Godfrey RW, Adelroth E, Nelson F, Rogers A, Johansson SA. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. Am Rev Respir Dis 1992;145:890-9.
8. Martin AJ, Landau LI, Phelan PD. Lung function in young adults who had asthma in childhood. Am Rev Respir Dis 1980;122:609-16.
9. McNicol KN, Williams HE. Spectrum of asthma in children. I. Clinical and physiological components. BMJ 1973;4:7-11.
10. McNicol KN, Williams HE. Spectrum of asthma in children. II. Allergic components. BMJ 1973;4:12-6.
11. Sorva R, Metso T, Turpeinen M, Juntunen-Backman K, Bjorksten F, Haahtela T. Eosinophil cationic protein in induced sputum as a marker of inflammation in asthmatic children. Pediatr Allergy Immunol 1997;8:45-50.
12. Adelroth E, Rosenhall L, Johansson SA, Linden M, Venge P. Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage. Am Rev Respir Dis 1990;142:91-9.
13. Wilson JW. What causes airway remodelling in asthma? Clin Exp Allergy 1998;28:534-6.
14. Agertoft L, Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994;88:373-81.
15. Haahtela T, Jarvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K, et al. Effects of reducing or discontinuing budesonide in patients with mild asthma. N Engl J Med 1994;331:700-5.
16. Kelly WJW, Hudson I, Phelan PD, Pain MCF, Olinsky A. Childhood asthma in adult life: a further study at 28 years of age. BMJ 1987;294:1059-62.
17. Siegel SC, Rachelefsky GS. Asthma in infants and children. Part I. J Allergy Clin Immunol 1985;76:1-15.
18. Croner S, Kjellman NIM. Natural history of bronchial asthma in childhood. A prospective study from birth up to 12-14 years of age. Allergy 1992;47:150-7.
19. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and wheezing in the first six years of life. N Engl J Med 1995;332:133-8.
20. Rubinstein A. The natural history of allergic disease and asthma in childhood. In: Schatz MS, Zeiger, RS, Claman H, editors. Asthma, allergy, and immunologic disorders in pregnancy and early infancy. Lung biology in health and disease, vol 110. New York: Marcel Dekker, Inc; 1997. p. 703-59.
21. Oswald H, Phelan PD, Lanigan A, Hibbert M, Carlin JB, Bowes G, et al. Childhood asthma and lung function in mid-adult life. Pediatr Pulmonol 1997;23:14-20.
22. Strachan D, Gerritsen J. Long-term outcome of early childhood wheezing: population data. Eur Respir J 1996;9(Suppl 21):42s-7s.
23. CAMP corporate paper. The Childhood Asthma Management Program (CAMP): design, rationale, and methods. Control Clin Trials 1999;20:91-120.
24. The National Asthma Education and Prevention Program guidelines. Bethesda (MD): National Heart, Lung and Blood Institute; June 1991. NHLBI Publication No. 91-3042A.
25. Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. Changes in the normal maximal expiratory flow volume curve with growth and aging. Am Rev Respir Dis 1983;127:725-34.
26. Coultas DB, Howard CA, Skipper BJ, Samet JM. Spirometric prediction equations for Hispanic children and adults in New Mexico. Am Rev Respir Dis 1988;135:1386-92.
27. Cockcroft DW, Killian DN, Mellon JJA, Hargreave FE. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy 1977;7:235-43.
28. Juniper EF, Frith PA, Dunnett C, Cockcroft DW, Hargreave FE. Reproducibility and comparison of responses to inhaled histamine and methacholine. Thorax 1978;33:705-10.
29. Childhood Asthma Management Program Study Group. Childhood Asthma Management Program methacholine challenge testing manual, version 3.0, and spirometry manual, version 3.0. Springfield (VA): National Technical Information, US Department of Commerce; 1994. Accession no. PB95-137154 and PB95-137113.
30. Childhood Asthma Management Program Study Group. Childhood Asthma Management Program allergy and skin test manual, version 2.0. Springfield (VA): National Technical Information Service, US Department of Commerce; 1994. Accession no. PB95-137188.
31. Wood R, Eggleston PA, Lind P, Ingemann L, Schwartz B, Graveson S, et al. Antigenic analysis of household dust samples. Am Rev Respir Dis 1988;137:358-63.
32. Hatcher L, Stepanski EJ. A step-by-step approach to using the SAS system for univariate and multivariate statistics. Cary (NC): SAS Institute, Inc; 1994.
33. Paganin F, Seneterre E, Chanez P, Daures JP, Bruel JM, Michel FB, et al. Computed tomography of the lungs in asthma: influence of disease severity and etiology. Am J Respir Crit Care Med 1996;153:110-4.
34. Dompeling E, van Schayck CP, van Grunsven PM, van Herwaarden CLA, Akkermans R, Molema J, et al. Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids. A 4-year prospective study. Ann Intern Med 1993;118:770-8.
35. Selroos O, Pietinalho A, Lofroos AB, Riska H. Effect of early vs late intervention with inhaled corticosteroids in asthma. Chest 1995;108:1228-34.
36. Mosfeldt LE, Kaae HK, Backer V, Bach-Mortensen N, Prahl P, Kock C. Pulmonary function in adolescents with childhood asthma. Allergy 1993;48:267-72.
37. Gold DR, Tager IB, Weiss ST, Tosteson TD, Speizer FE. Acute lower respiratory illness in childhood as a predictor of lung function and chronic respiratory symptoms. Am Rev Respir Dis 1989;140:877-84.
38. Gold DR, Wypij D, Wang X, Speizer FE, Pugh M, Ware JH, et al. Gender- and race-specific effects of asthma and wheeze on level and growth of lung function in children in six U.S. cities. Am J Respir Crit Care Med 1994;149:1198-208.
39. Sherrill D, Sears MR, Lebowitz MD, Holdaway MD, Hewitt CJ, Flannery EM, et al. The effects of airway hyperresponsiveness, wheezing, and atopy on longitudinal pulmonary function in children: a 6-year follow-up study. Pediatr Pulmonol 1992;13:78-85.
40. Henderson FW, Stewart PW, Burchinal MR, Voter KZ, Strope GL, Ivins SS, et al. Respiratory allergy and the relationship between early childhood lower respiratory illness and subsequent lung function. Am Rev Respir Dis 1992;145:283-90.
41. Zeiger RS, Heller S. The development and prediction of atopy in high-risk children: follow-up at age seven years in a prospective randomized study of combined maternal and infant food allergen avoidance. J Allergy Clin Immunol 1995;95:1179-90.
42. Cookson WOCM, De Klerk NH, Ryan GR, James AL, Musk AW. Relative risks of bronchial hyper-responsiveness associated with skin-prick test responses to common antigens in young adults. Clin Exp Allergy 1991;21:473-9.
43. Mensinga TT, Scheuten JP, Weiss ST, Van Der Lende R. Relationship of skin test reactivity and eosinophilia to level of pulmonary function in a community-based population study. Am Rev Respir Dis 1992;146:638-43.
44. Ulrik CS. Peripheral eosinophil counts as a marker of disease activity in intrinsic and extrinsic asthma. Clin Exp Allergy 1995;25:820-7.
45. Frette C, Annesi I, Korobaeff M, Neukirch F, Dore MF, Kauffmann F. Blood eosinophilia and FEV1. Cross-sectional and longitudinal analyses. Am Rev Respir Dis 1991;143:987-92.
46. Kelly WJW, Hudson I, Phelan PD, Pain MCF, Olinsky A. Atopy in subjects with asthma followed to the age of 28 years. J Allergy Clin Immunol 1990;85:548-57.
47. Peat JK, Tovey E, Toelle BG, Haby MM, Gray EJ, Mahmic A, et al. House dust mite allergens. A major risk factor for childhood asthma in Australia. Am J Respir Crit Care Med 1996;153:141-6.
48. Sears MR, Burrows B, Herbison GP, Flannery EM, Holdaway MD. Atopy in childhood. III. Relationship with pulmonary function and airway responsiveness. Clin Exp Allergy 1993;23:957-63.
49. CAMP Research Group. Recruitment in the Childhood Asthma Management Program (CAMP). I. Description of methods. J Asthma. In press.